By Liz Moyer
Investing.com -- U.S. stocks rose as investors tried to reverse a multi-day losing streak sparked by global growth concerns.
At 10:35 ET (14:35 GMT), the Dow Jones Industrial Average was up 228 points or 0.8%, while the S&P 500 rose 0.8%, and the NASDAQ Composite was up 0.6%.
The Bank of England, trying to stabilize the pound's rapid descent, said it would buy long-dated government bonds.
Meanwhile, the yield on the U.S. 10-year Treasury bill backed off of 12-year highs and Germany's benchmark 10-year government bond yield fell from an 11-year high.
Today features appearances and speeches from a number of Federal Reserve officials, including Chair Jerome Powell and James Bullard. Investors have worried that the Fed's aggressive stance on taming inflation could tip the economy into a recession, though expectations are that the central bank will continue on its path of interest rate increases.
Stocks were also moving after a report that Apple Inc. (NASDAQ:AAPL) will not increase production of its iPhone 14, sending its own shares down more than 3%.
Shares of Biogen Inc. (NASDAQ:BIIB) surged 36% after its drug development partner Eisai Co. (TYO:4523) reported positive results from a trial of their latest Alzheimer's drug. Eli Lilly and Company (NYSE:LLY) shares rose 9%.
Investors were keeping an eye on Hurricane Ian, which is about to slam into the west coast of Florida, shutting down flights to and from the region and with the potential to cause severe damage.
Oil rose. Crude Oil WTI Futures was up 3.3%, to $81.09 a barrel, and Brent Oil Futures crude was up 2.5% to $87 a barrel. Gold Futures rose 1.5% to $1660.
Begin trading today! Create an account by completing our form
At One Financial Markets we are committed to safeguarding your privacy.
Please see our Privacy Policy for details about what information is collected from you and why it is collected. We do not sell your information or use it other than as described in the Policy.
Please note that it is in our legitimate business interest to send you certain marketing emails from time to time. However, if you would prefer not to receive these you can opt-out by ticking the box below.
Alternatively, you can use the unsubscribe link at the bottom of the Demo account confirmation email or any subsequent emails we send.
By completing the form and downloading the platform you agree with the use of your personal information as detailed in the Policy.